Summary
Darunavir (DRV) is a poorly water-soluble anti-HIV drug, so improving its dissolution while protecting it from the acidic stomach is valuable for oral delivery. This study tests whether both goals can be met in a single manufacturing step using coaxial electrospraying to make core–shell nanoparticles. The core was a solution of darunavir with hydroxypropyl methylcellulose (HPMC) — forming a solid dispersion that keeps the drug in a fast-dissolving amorphous state — while the shell was an enteric polymer (Eudragit L100) that resists dissolution at low pH and releases in the intestine. The resulting particles were characterised for morphology, physical (amorphous) state, encapsulation efficiency and in-vitro dissolution, demonstrating that coaxial electrospraying can produce enteric-coated amorphous solid-dispersion nanoparticles of darunavir in one step.
Authors & Affiliations
Duong Nhat Nguyen
Drug Delivery and Disposition, Dept. of Pharmaceutical & Pharmacological Sciences,
KU Leuven, Belgium
Ljiljana Palangetic
Dept. of Chemical Engineering,
KU Leuven, Belgium
Christian Clasen
Dept. of Chemical Engineering,
KU Leuven, Belgium
Guy Van den Mooter Corresponding
Drug Delivery and Disposition, Dept. of Pharmaceutical & Pharmacological Sciences,
KU Leuven, Belgium
Topics
Coaxial Electrospraying
Amorphous Solid Dispersion
Enteric Coating
Oral Drug Delivery
Materials
Darunavir (DRV)
Hydroxypropyl Methylcellulose (HPMC)
Eudragit L100
Linari Electrospinning Systems
Coaxial electrospinning needles by Linari Nanotech
These core–shell particles are produced by coaxial electrospraying. Linari Nanotech supplies coaxial (core-shell) needle emitters for encapsulating a drug-loaded core within an enteric polymer shell.
Read the full publication